Vanguard Group Inc Exact Sciences Corp Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Vanguard Group Inc holds 18,175,271 shares of EXAS stock, worth $1.26 Billion. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,175,271
Previous 17,740,092
2.45%
Holding current value
$1.26 Billion
Previous $1.23 Billion
37.32%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding EXAS
# of Institutions
635Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Capital World Investors Los Angeles, CA16.5MShares$1.14 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$1.03 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$837 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$569 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.34MShares$301 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $12.3B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...